Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) General Information

Description

Commercial, distribution and IP rights for Urea Cycle Disorders products, Ravicti and Ammonaps, outside North America and Europe.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Japan
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights)‘s full profile, request access.

Request a free trial

Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights)‘s full profile, request access.

Request a free trial

Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) FAQs

  • Where is Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) headquartered?

    Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) is headquartered in Japan.

  • What industry is Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) in?

    Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights)’s primary industry is Buildings and Property.

  • Is Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) a private or public company?

    Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) is a Private company.

  • What is the current valuation of Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights)?

    The current valuation of Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) is .

  • What is Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights)’s current revenue?

    The current revenue for Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) is .

  • Who are Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights)’s investors?

    Horizon Therapeutics has invested in Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights).

  • When was Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) acquired?

    Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) was acquired on 27-Dec-2018.

  • Who acquired Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights)?

    Medical Need Europe (Ravicti and Ammonaps commercial, distribution and IP rights) was acquired by Medical Need.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process